NL-OMON55316已完成不适用
Isolation of COVID-19-Specific neutralizing Antibodies from COVID-19 patients for therapeutic and prophylactic use - The COSCA study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •-written informed consent to participate in the study and store samples
- •-age between 18 and 75 years
- •- PCR confirmed SARS-CoV-2 infection
- •- able to visit the Amsterdam UMC, location AMC 3-8 weeks after onset of
- •COVID-19 symptoms. In the absence of symptoms, patients will visit the
- •Amsterdam UMC, location AMC 3-8 weeks after PCR confirmation. A home visit by
- •the study team is a possibility when the patient is unable to travel to the
- •Amsterdam UMC.
排除标准
- •-mental disorder that in the view of the investigator would interfere with
- •adherence to the treatment or the study procedures, or the decision to
- •participate in the study.
- •-use of immunosuppressive medication (equivalent of > 7.5mg prednisolone /
- •day). Note: Patients with only a short course of immunosuppressive medication
- •can still participate.
研究者
相似试验
尚未招募
不适用
Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease SeverityCOVID-19TCTR20210329003King Chulalongkorn Memorial Hospital Excellence Center Program,36
进行中（未招募）
1 期
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies after COVID-19 Booster Vaccines – The CoVVacBoost Study - The CoVVacBoost StudyCovid (Coronavirus disease)- 19 immunisationMedDRA version: 23.1Level: PTClassification code 10084457Term: COVID-19 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2021-006172-16-ATMedical University of Graz1,200
尚未招募
不适用
Post-Coronavirus Disease 2019 (COVID-19) Antibody levels in End-Stage Renal Disease (ESRD) patientsEnd-stage renal disease patients with renal replacement therapy recovered from COVID-19End stage kidney diseaseCOVID-19SARS-CoV-2Post COVID-19RRTRenal replacement therapyESRDTCTR20211005004Bamrasnaradura Infectious Diseases Institute50
招募中
不适用
Identification of neutralizing antibodies against severe or chronic infections of human beingDRKS00010169niversitätsklinikum Köln1,000
尚未招募
不适用
Determination of the SARS-CoV-2/COVID-19 seroprevalence of patients in emergency rooms at the university hospitals in North Rhine-WestphaliaSeroprevalence of SARS-CoV-2 antibodies in emergency room patientsDRKS00029414Institut für Virologie Uniklinik Köln3,000